¹³¹I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

This publication has 25 references indexed in Scilit:

• A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911
  Blood, 2003
• The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I 131 tositumomab
  Seminars in Oncology, 2003
• Treatment-Related Myelodysplasia and Acute Leukemia in Non-Hodgkin’s Lymphoma Patients
  Journal of Clinical Oncology, 2003
• Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma
  Blood, 2002
• Radioimmunotherapy with Iodine-131 Tositumomab in Patients with Low-Grade Non-Hodgkin's B-Cell Lymphoma Does Not Induce Loss of Acquired Humoral Immunity against Common Antigens
  Clinical Immunology, 2001
• Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
  Blood, 2001
• Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma
  New England Journal of Medicine, 1993
• Radioimmunotherapy of B-Cell Lymphoma with [¹³¹I]Anti-B1 (Anti-CD20) Antibody
  New England Journal of Medicine, 1993
• Stage I and II non-hodgkin's lymphomas: Long-term results of radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes
  European Journal of Immunology, 1986